Tang M - Search Results

1

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.

Tang M, Price TJ, Shapiro J, Gibbs P, Haller DG, Arnold D, Peeters M, Segelov E, Roy A, Tebbutt N, Pavlakis N, Karapetis C, Burge M. Tang M, et al. Expert Rev Anticancer Ther. 2018 Apr;18(4):339-349. doi: 10.1080/14737140.2018.1444481. Epub 2018 Mar 1. Expert Rev Anticancer Ther. 2018. PMID: 29478352 Review.

2

Emergency department presentations in early stage breast cancer patients receiving adjuvant and neoadjuvant chemotherapy.

Tang M, Horsley P, Lewis CR. Tang M, et al. Intern Med J. 2018 May;48(5):583-587. doi: 10.1111/imj.13785. Intern Med J. 2018. PMID: 29722200

3

Targeted therapy for metastatic colorectal cancer.

Price TJ, Tang M, Gibbs P, Haller DG, Peeters M, Arnold D, Segelov E, Roy A, Tebbutt N, Pavlakis N, Karapetis C, Burge M, Shapiro J. Price TJ, et al. Among authors: tang m. Expert Rev Anticancer Ther. 2018 Oct;18(10):991-1006. doi: 10.1080/14737140.2018.1502664. Epub 2018 Aug 3. Expert Rev Anticancer Ther. 2018. PMID: 30019590 Review.

4

Challenges of international oncology trial collaboration-a call to action.

Tang M, Joensuu H, Simes RJ, Price TJ, Yip S, Hague W, Sjoquist KM, Zalcberg J. Tang M, et al. Br J Cancer. 2019 Oct;121(7):515-521. doi: 10.1038/s41416-019-0532-4. Epub 2019 Aug 5. Br J Cancer. 2019. PMID: 31378784 Free PMC article. Review.

5

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015).

Daniels B, Kiely BE, Tang M, Tervonen H, Pearson SA. Daniels B, et al. Among authors: tang m. BMC Cancer. 2019 Sep 11;19(1):909. doi: 10.1186/s12885-019-6126-y. BMC Cancer. 2019. PMID: 31510955 Free PMC article.

6

Magnetic nanoparticles: prospects in cancer imaging and therapy.

Tang M, Russell PJ, Khatri A. Tang M, et al. Discov Med. 2007 Jun;7(38):68-74. Discov Med. 2007. PMID: 18093468 Free article.

7

Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.

Tervonen HE, Daniels B, Tang M, Preen DB, Pearson SA. Tervonen HE, et al. Among authors: tang m. Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):812-820. doi: 10.1002/pds.4751. Epub 2019 Mar 12. Pharmacoepidemiol Drug Saf. 2019. PMID: 30861596

8

Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study.

Tang M, Schaffer AL, Kiely BE, Daniels B, Lee CK, Simes RJ, Pearson SA. Tang M, et al. Breast Cancer Res Treat. 2021 Jun;187(3):893-902. doi: 10.1007/s10549-021-06135-5. Epub 2021 Feb 22. Breast Cancer Res Treat. 2021. PMID: 33616773

9

Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort.

Daniels B, Kiely BE, Tang M, Houssami N, Lord SJ, Pearson SA. Daniels B, et al. Among authors: tang m. Breast. 2021 Aug;58:106-112. doi: 10.1016/j.breast.2021.05.001. Epub 2021 May 7. Breast. 2021. PMID: 33992964 Free PMC article.

10

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.

Tang M, O'Connell RL, Amant F, Beale P, McNally O, Sjoquist KM, Grant P, Davis A, Sykes P, Mileshkin L, Moujaber T, Kennedy CJ, deFazio A, Tan K, Antill Y, Goh J, Bonaventura T, Scurry J, Friedlander M. Tang M, et al. Gynecol Oncol. 2019 Sep;154(3):531-538. doi: 10.1016/j.ygyno.2019.06.011. Epub 2019 Jun 18. Gynecol Oncol. 2019. PMID: 31227223 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,797 results

Search Page

Filters